Andrew Scott Kennedy
Department of Cardiology
Unidad de Tecnología Marina
Dr. Andrew Scott Kennedy, co-medical director for Wake Radiology Oncology Services, and Director of the Liver Cancer Program in Cary, NC, USA. He is also currently adjunct associate professor of Department of Mechanical and Aerospace Engineering and Department of Biomedical Engineering at North Carolina State University, Raleigh, North Carolina, USA. He is an internationally renowned radiation oncologist specializing in gastrointestinal cancers, as well as cancers of the breast and lung. He has given numerous presentations on radiation therapy for the treatment of colorectal and liver cancer worldwide and was instrumental in reintroducing liver radiotherapy via microspheres back into the USA in August 2000. Since then he has published extensively on microsphere radiotherapy and is considered a key opinion leader and champion of this treatment approach. Dr. Kennedy developed the most commonly used protocol in the USA for use of microspheres and is the recipient of more than 1,000,000 dollars in research grants to further investigate this and other cancer treatments. Dr. Kennedy has also received grants from the University Of Maryland School of Medicine to study new treatments in GI and lung cancers using radiation combined with chemotherapy aided by molecular markers. He has written dozens of articles, book chapters and abstracts on preclinical, clinical and techniques in radiation oncology and has been invited to give presentations on radiation therapy for GI cancers and infusion of microspheres at the premier medical conferences in the United States, Asia and Europe. He is a leading instructor/proctor of microsphere therapy to medical teams worldwide. Dr. Kennedy is a graduate of Loma Linda School of Medicine, in Loma Linda, California, USA and completed residency at The University of North Carolina at Chapel Hill. As chief resident, and later a research fellow, he completed significant work in three-dimensional treatment planning (3D external beam radiation therapy) and radiobiology research. He served as an associate professor in the Radiation Oncology and Head of GI Radiation Oncology at The University of Maryland School of Medicine, and Residency Program Director from 1997-2002 messages 1978 University of Wyoming BSc, Nutrition and Food Science 1979 University of Utah Medical center MD 1983 Mayo Clinic Rochester Residency, Internal Medicine 1983 - 1986Mayo Clinic Rochester Fellowship, Hematology 1987 - 1989 University of Washington Residency, Nuclear Medicine 1989 - 1990 University of Washington Fellowship, Oncology 1989 - 1992 University of Washington Chief Resident, Nuclear Medicine 1991 - 1992
His research interest includes Pharmacology, Chemical Biology, Pathology.